99% Purity Pharmaceutical Raw Material Bimatoprost for Eyelash Growth

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: TGY022019050503
• Product Name: Bimatoprost
• Specificcation: 99%
• Grade: Pharmaceuticals Grade
• Shelf Life: 2 Years
• Storage: Cool Dry Place
• Shipping Time: Within 3-7 Working Days
• CAS: 155206-00-1
• Appearance: White Powder
• Transport Package: Foil Bag, Box, Drum
• Specification: 99% min
• Trademark: TGY
• Origin: China
• HS Code: 300440906
• Production Capacity: 150kg/Month

Product Description

_{Name:Bimatoprost
Synonyms:N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; ; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST; 17-phenyl-tri-norprostaglandin f2-ethyl amide; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
CAS No.:155206-00-1
MF:C25H37NO4
MW:415.5656
Purity:99%
Appearance:White crystal Powder}

_{Bimatoprost (marketed in the U.S., Canada and Europe by Allergan, ) is aprostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluidfrom the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.}

<sub>Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
Packing foil bag or as required.

COA of Bimatoprost:</sub>
 

TEST	SPECIFICATIONS	RESULTS
Appearance	White to yellow crystalline powder	White crystalline powder
Identification	A. Should meet the requirement	Conforms
	B. Should meet the requirement	Conforms
Impurity A	≤0.5%	N.D.
Impurity B	≤0.3%	0.075%
Loss on drying	≤0.5%	0.085%
Residue on Ignition	≤0.1%	0.045%
Residual solvent	Eth≤0.5%	0.026%
	Eth≤0.5%	N.D.
	Tetra≤0.072%	N.D.
Heavy Metal	≤20ppm	Conforms
Assay	98.0%~102.0% (Calculated on the dried basis)	99.5%